The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain - PubMed (original) (raw)
. 2006 Mar 1;97(4):882-92.
doi: 10.1002/jcb.20645.
Affiliations
- PMID: 16265664
- DOI: 10.1002/jcb.20645
The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain
Cong Peng et al. J Cell Biochem. 2006.
Abstract
Studies showed that the bromodomain binds to acetyl-lysines on histone tails, which is involved in deciphering the histone codes. BRD7, a novel bromodomain gene, is the first described bromodomain gene involved in nasopharyngeal carcinoma (NPC). Previous studies showed that ectopic expression of BRD7 inhibited cell growth and cell cycle progression from G1 to S phase in HNE1 cells (a NPC cell line) by transcriptionally regulating some cell cycle related genes including E2F3 gene. In the present study, we revealed the co-localization between acetylated H3 and BRD7 and found that the bromodomain of BRD7 is required for this co-localization. More importantly, wild-type BRD7 interacted with H3 peptide acetylated at Lys14, while the bromodomain deleted mutant lost this ability. We also found that the mutant BRD7 failed to regulate E2F3 promoter activity and inhibit cell cycle progression. These results indicated that the transcriptional regulation role of BRD7 was achieved by binding to acetylated histone H3 and that the bromodomain was essential for this role. In addition, no obvious changes were observed in the acetylated level of histone H3 after transfection with BRD7, indicating that chromatin remodeling, not chromatin modification, is the major mechanism of BRD7 mediated gene transcription. Taken together, the present work shed light on the fact that a novel bromodomain gene, BRD7, is of importance in transcriptional regulation and cellular events including cell cycle.
2005 Wiley-Liss, Inc.
Similar articles
- BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
Zhou J, Ma J, Zhang BC, Li XL, Shen SR, Zhu SG, Xiong W, Liu HY, Huang H, Zhou M, Li GY. Zhou J, et al. J Cell Physiol. 2004 Jul;200(1):89-98. doi: 10.1002/jcp.20013. J Cell Physiol. 2004. PMID: 15137061 - Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4.
Sun H, Liu J, Zhang J, Shen W, Huang H, Xu C, Dai H, Wu J, Shi Y. Sun H, et al. Biochem Biophys Res Commun. 2007 Jun 29;358(2):435-41. doi: 10.1016/j.bbrc.2007.04.139. Epub 2007 May 2. Biochem Biophys Res Commun. 2007. PMID: 17498659 - Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression.
Zhou M, Liu H, Xu X, Zhou H, Li X, Peng C, Shen S, Xiong W, Ma J, Zeng Z, Fang S, Nie X, Yang Y, Zhou J, Xiang J, Cao L, Peng S, Li S, Li G. Zhou M, et al. J Cell Biochem. 2006 Jul 1;98(4):920-30. doi: 10.1002/jcb.20788. J Cell Biochem. 2006. PMID: 16475162 - Structure and acetyl-lysine recognition of the bromodomain.
Mujtaba S, Zeng L, Zhou MM. Mujtaba S, et al. Oncogene. 2007 Aug 13;26(37):5521-7. doi: 10.1038/sj.onc.1210618. Oncogene. 2007. PMID: 17694091 Review. - Epigenetic regulation of airway inflammation.
Adcock IM, Tsaprouni L, Bhavsar P, Ito K. Adcock IM, et al. Curr Opin Immunol. 2007 Dec;19(6):694-700. doi: 10.1016/j.coi.2007.07.016. Epub 2007 Aug 27. Curr Opin Immunol. 2007. PMID: 17720468 Review.
Cited by
- The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription.
LeRoy G, Rickards B, Flint SJ. LeRoy G, et al. Mol Cell. 2008 Apr 11;30(1):51-60. doi: 10.1016/j.molcel.2008.01.018. Mol Cell. 2008. PMID: 18406326 Free PMC article. - Driver mutations of cancer epigenomes.
Roy DM, Walsh LA, Chan TA. Roy DM, et al. Protein Cell. 2014 Apr;5(4):265-96. doi: 10.1007/s13238-014-0031-6. Epub 2014 Mar 14. Protein Cell. 2014. PMID: 24622842 Free PMC article. - BRD7 regulates XBP1s' activity and glucose homeostasis through its interaction with the regulatory subunits of PI3K.
Park SW, Herrema H, Salazar M, Cakir I, Cabi S, Basibuyuk Sahin F, Chiu YH, Cantley LC, Ozcan U. Park SW, et al. Cell Metab. 2014 Jul 1;20(1):73-84. doi: 10.1016/j.cmet.2014.04.006. Epub 2014 May 15. Cell Metab. 2014. PMID: 24836559 Free PMC article. - BRD7 Stabilizes P53 via Dephosphorylation of MDM2 to Inhibit Tumor Growth in Breast Cancer Harboring Wild-type P53.
Luo Y, Wang X, Niu W, Zhou Y, Li M, Ma J, Yang J, Fan S, Zeng Z, Xiong W, Li X, Li G, Xiao J, Zhou M. Luo Y, et al. J Cancer. 2022 Feb 28;13(5):1436-1448. doi: 10.7150/jca.67447. eCollection 2022. J Cancer. 2022. PMID: 35371302 Free PMC article. - Emerging Roles of BRD7 in Pathophysiology.
Park SW, Lee JM. Park SW, et al. Int J Mol Sci. 2020 Sep 27;21(19):7127. doi: 10.3390/ijms21197127. Int J Mol Sci. 2020. PMID: 32992509 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases